Â
Latest Gallbladder Treatment Companies Update
November 2023, Intuitive Surgical received FDA approval for its da Vinci SP robot, a smaller and more portable version of their flagship surgical robot specifically designed for minimally invasive laparoscopic surgeries, including laparoscopic cholecystectomy (gallbladder removal). This could potentially enhance access to minimally invasive gallbladder surgery in smaller hospitals and clinics.
Stryker's Monarchâ„¢ Energy Tissue Ablation System received CE Mark approval for its Monarchâ„¢ Energy Tissue Ablation System in January 2023. This system uses radiofrequency energy to ablate gallstones within the gallbladder, offering a potential alternative to surgery for select patients.
Novel Diagnostic Tools Companies are developing advanced imaging and biomarker tests to improve early diagnosis of gallbladder disease and personalize treatment options. For example, Exact Sciences is exploring the potential of its Cologuard® stool DNA test for detecting early-stage gallbladder cancer.
Galena Biopharma's GB004 Phase 2b Trial Galena Biopharma is conducting a Phase 2b trial for its GB004 oral therapy for non-alcoholic fatty liver disease (NAFLD), a major risk factor for gallstones. Positive results could significantly impact the market landscape.
Endoceutics' RECEIBAâ„¢ System Endoceutics received FDA approval for its RECEIBAâ„¢ System, a minimally invasive device for gallstone removal through the mouth (transoral endoscopy). This advancement offers a potential alternative to traditional laparoscopic or open surgery for certain patients.
List of Gallbladder Treatment Key Companies in the Market
- Boston Scientific Corporation
- Intuitive Surgical
- R. Bard Inc.
- Dornier MedTech
- Koninklijke Philips N.V.
- Braun Melsungen AG
- Sanofi